The Expression Pattern and Regulatory Mechanism of the G0/G1 Switch Gene 2 (<i>G0S2</i>) in the Pathogenesis and Treatment of AChR Myasthenia Gravis (MG)

<div>The expression level of G0S2 in the PMBC with different treatment. MG means the PMBC sample from myasthenia gravis patients; DAC means PMBC sample cocultured with DAC(5-aza-dC) to perform DNA demethylation. NFAT5 means PMBC sample which was transfected with P-EGF-N1-NFAT5 plasmid; DAC+NFAT5 means PMBC sample which were transfected with P-EGF-N1-NFAT5 plasmid after coculturing with DAC(5-aza-dC).</div>

Mediators of Inflammation

fig8

Figure 8

Figure 8: The Expression Pattern and Regulatory Mechanism of the G0/G1 Switch Gene 2 (<i>G0S2</i>) in the Pathogenesis and Treatment of AChR Myasthenia Gravis (MG) 

Figure 8 | The Expression Pattern and Regulatory Mechanism of the G0/G1 Switch Gene 2 (G0S2) in the Pathogenesis and Treatment of AChR Myasthenia Gravis (MG) 